Teva Pharmaceuticals and Alvotech said on Friday they have launched a biosimilar to Johnson & Johnson's autoimmune drug Stelara in the United States. Selarsdi, like Stelara, is approved for the ...
Teva (TEVA) stock and Alvotech (ALVO) stock in focus as duo launches Selarsdi, a biosimilar to J&J's (JNJ) Stelara after a ...
2d
Irish Star on MSNJohnson & Johnson legal battle over baby powder's 'link to cancer' begins in $10 billion caseA $10 billion settlement to end litigation over Johnson & Johnson's baby powder, which was recalled after it was alleged to ...
Bryan Johnson injected himself with ketamine, a hallucinogen favored by Elon Musk, for 15 days. He used a helmet from his ...
Johnson & Johnson may outshine AbbVie as a top defensive stock pick. Read how Ben Graham's framework evaluates each ...
Healthcare conglomerate Johnson & Johnson kicks off its bankruptcy plan confirmation Tuesday, in its third attempt to resolve ...
After the rejection of Lykos Therapeutics’ MDMA-based PTSD treatment tempered excitement for psychedelic therapeutics, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results